GMAB: 3 Biotech Stocks Gaining Altitude and Interest
This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy…
59,940$
-0,37%
Echtzeit-Aktienkurs BioMarin Pharmaceutical
Bid:
Ask: